Nonstructural 3/4A Protease of Hepatitis C Virus Activates Epithelial Growth Factor-Induced Signal Transduction by Cleavage of the T-Cell Protein Tyrosine Phosphatase
Nonstructural 3/4A Protease of Hepatitis C Virus Activates Epithelial Growth Factor-Induced Signal Transduction by Cleavage of the T-Cell Protein Tyrosine Phosphatase
复制标题
DOI:
10.1002/hep.22857
复制
发表时间:
2009-06-01
期刊:
影响因子:
13.5
通讯作者:
Bode, Johannes Georg
中科院分区:
文献类型:
--
作者:
Brenndorfer, Erwin Daniel;Karthe, Juliane;Bode, Johannes Georg
The hepatitis C virus (HCV) is a worldwide major cause of chronic liver disease with a high tendency to establish a persistent infection. To permit persistent replication of viral genomes through the cellular translation machinery without affecting host cell viability, viruses must have developed mechanisms to control cellular cascades required for sufficient viral replication, on the one hand, and to adapt viral replication to the cellular requirements on the other hand. The present study aimed to further elucidate mechanisms by which HCV targets growth factor signaling of the host cell and their implications for viral replication. The study describes a novel mechanism by which HCV influences the activation of the epithelial growth factor receptor/Akt pathway through a nonstructural (NS)3/4A-dependent down-regulation of the ubiquitously expressed tyrosine phosphatase T cell protein tyrosine phosphatase (TC-PTP). NS3/4A is demonstrated to cleave TC-PTP protease-dependently in vitro at two cleavage sites. The in vivo relevance of this finding is supported by the fact that down-regulation of TC-PTP protein expression could also be demonstrated in HCV-infected individuals and in transgenic mice with intrahepatic expression of NS3/4A. Conclusion: This down-regulation of TC-PTP results in an enhancement of epithelial growth factor (EGF)-induced signal transduction and increases basal activity of Akt, which is demonstrated to be essential for the maintenance of sufficient viral replication. Hence, therapeutic targeting of NS3/4A may not only disturb viral replication by blocking the processing of the viral polyprotein but also exerts unforeseen indirect antiviral effects, further diminishing viral replication. (HEPATOLOGY 2009;49:1810-1820.)